rs781194178
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 4P and 2B. PM2PP5_ModerateBP4BP7
The NM_001387111.3(POLK):c.1734G>A(p.Lys578Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Consequence
POLK
NM_001387111.3 synonymous
NM_001387111.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.39
Genes affected
POLK (HGNC:9183): (DNA polymerase kappa) This gene encodes a member of the DNA polymerase type-Y family of proteins. The encoded protein is a specialized DNA polymerase that catalyzes translesion DNA synthesis, which allows DNA replication in the presence of DNA lesions. Human cell lines lacking a functional copy of this gene exhibit impaired genome integrity and enhanced susceptibility to oxidative damage. Mutations in this gene that impair enzyme activity may be associated with prostate cancer in human patients. [provided by RefSeq, Sep 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 5-75596385-G-A is Pathogenic according to our data. Variant chr5-75596385-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 218226.Status of the report is criteria_provided_single_submitter, 1 stars.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42). . Strength limited to SUPPORTING due to the PP5.
BP7
Synonymous conserved (PhyloP=2.39 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POLK | NM_001387111.3 | c.1734G>A | p.Lys578Lys | synonymous_variant | 14/16 | NP_001374040.1 | ||
POLK | NM_001395894.1 | c.1734G>A | p.Lys578Lys | synonymous_variant | 15/17 | NP_001382823.1 | ||
POLK | NM_001395897.1 | c.1731G>A | p.Lys577Lys | synonymous_variant | 14/16 | NP_001382826.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POLK | ENST00000241436.9 | c.1692G>A | p.Lys564Lys | synonymous_variant | 13/15 | 1 | ENSP00000241436.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Malignant tumor of prostate Pathogenic:1
Pathogenic, criteria provided, single submitter | research | Tulane Cancer Center, Tulane University | Mar 05, 2014 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at